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Abstract
Autism spectrum disorder (ASD) is a neurological and developmental disorder characterized by social impairment and
restricted interactive and communicative behaviors. It may occur as an isolated disorder or in the context of other
neurological, psychiatric, developmental, and genetic disorders. Due to rapid developments in genomics and imaging
technologies, imaging genetics studies of ASD have evolved in the last few years. Increased risk for ASD diagnosis is
found to be related to many specific single-nucleotide polymorphisms, and the study of genetic mechanisms and
noninvasive imaging has opened various approaches that can help diagnose ASD at the nascent level. Identifying risk
genes related to structural and functional changes in the brain of ASD patients provide a better understanding of the
disease’s neuropsychiatry and can help identify targets for therapeutic intervention that could be useful for the clinical
management of ASD patients.
Introduction
Autism spectrum disorder (ASD) is a neurological and
developmental disorder consisting of a wide range of
symptoms and disability that develop in early childhood
and persists throughout life. The common symptoms of
ASD include limited activities, lower engagement and
communication, talking and learning problems, and
repetitive behavior. According to the World Health
Organization, the global burden of ASD is continuously
growing, with a current prevalence rate of 1 in 160 chil-
dren. Reported prevalence rates vary widely from country
to country though. Recent data from the Centers for
Disease Control and Prevention showed that about 1 in 68
children in the United States had been identified with
some form of ASD, with more than 3 million people
affected1. A recent study estimated prevalence of ASD in
the United States in 2014–2016 was 2.47% among ado-
lescents and children2. While in the United Kingdom, the
annual prevalence rate for children aged 8 years between
2004 and 2010 was 3.8/1000 for boys and 0.8/1000 for
girls3. Recent studies have shown that the pooled ASD
prevalence estimate in Asia is 0.36%, including data from
nine countries (China, Korea, India, Bangladesh, Lebanon,
Iran, Israel, Nepal and Sri Lanka)4. The prevalence of ASD
in the Middle East region was documented to be 1.4 per
10,000 children in Oman5, 4.3 per 10,000 children in
Bahrain6, 1/167 in Saudi Arabia7, and a recent study
reported ASD prevalence to be 1.14 % in children aged
6–11 years in Qatar8.
ASD incidence is 4–5 times greater in males than in
females9. The exact cause of ASD remains unclear; how-
ever, it is thought that both genetic and environmental
factors play essential roles. The effect of ASD on society is
enormous and multifaceted as it affects not only the child
but also the siblings and parents and significantly disturbs
the functioning of family routine life. Individuals with
ASD are very likely to encounter the criminal justice
system, mostly due to a lack of knowledge of their social
and communication difficulties. There are also financial
pressures associated with the recovery and decreased
opportunities for jobs. Various studies have focused on
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the problems faced by families of autistic children10. It
may affect the performance of the child at school, based
on the severity of the disorder, and if untreated or
undiagnosed, it may continue into adulthood, affecting
both personal and professional life. Although there is no
standard treatment for ASD, early detection and use of
successful therapies can make a difference in the man-
agement and improvement of symptoms, and thus the
overall quality of life of children with ASD. Before the
clinical symptoms occur, therefore, a consensus is reached
in treating ASD based on early detection.
Recent cohort studies have reported that hereditary
factors can be traced to more than 50% of autism cases11.
Historically, the genetic essence of ASD has been identi-
fied in family and twin studies12,13. The study of family
exome sequencing has found some rare de novo mutations
in people with ASD as opposed to healthy controls. It is
estimated that ~1000 genes are involved in autism14,15. On
the other hand, the main variants associated with autism16
are yet to be identified in genome-wide association studies.
By understanding the evidence at gene expression, we will
obtain a complete understanding of autism which can aid
in the clinical treatment of patients with ASD.
On the other hand, noninvasive imaging provides
information on the structural and functional changes of
autism in the brain. Studies have shown that connecting
genomics to imaging can provide a better understanding
of ASD’s pathophysiology17 and can help develop ther-
apeutic approaches to prevent or reverse ASD brain
changes. In this review article, as demonstrated in the
imaging, we illustrate how genetic variations are correlated
with the structural and functional changes in the brain.
Changes in the autistic brain
Pathological findings
Postmortem studies conducted on autistic brains helped
to identify the neuroanatomical changes associated with
ASD. Smaller cell size and increased density of cells in the
hippocampus, limbic system, entorhinal cortex, and
amygdala have been observed in all ages of ASD indivi-
duals18. Young patients with autism showed abnormally
enlarged neurons in the cerebellar nuclei, inferior olive,
and vertical limb of the diagonal band of broca18. Another
postmortem study found an increased number of neurons
in the prefrontal cortex in the brain of ASD children19.
Purkinje cell count was found to be decreased in the
archicerebellar and neocerebellar cortices of the cerebellar
hemisphere in autistic patients20. Another study observed
a reduced number of small pale neurons in the brains of
adult autistic patients21. A postmortem study of the brain
of patients with ASD also reported altered axonal density
and the presence of impaired myelin in white matter
(WM)22. Overall, the pathological findings suggest a
restricted brain development pattern in ASD patients.
Structural brain changes
Brain changes in ASD patients have been primarily
studied using magnetic resonance imaging (MRI). MRI is
the most widely used noninvasive modality to examine the
structural and functional brain changes in different neu-
rological and neurodegenerative disorders. Various MR-
based methods are applied to study the morphological,
functional, and metabolic changes in the brain of ASD.
MRI findings in children with ASD ranging from 2 to 5
years of age revealed that there is an abnormal develop-
ment of frontal and temporal lobes, lower gray matter
(GM), WM, and amygdala volume compared to same-age
healthy controls23. A comparison of the brain morpho-
metric features in 3–4 years old ASD children with typi-
cally developing (TD) children and developmentally
delayed children24 was conducted using high-resolution
3-D MRI. Increased cerebellar volume was found in
children with ASD compared to TD, and developmentally
delayed children and amygdala enlargement with
increased cerebral volume was seen in ASD children24.
Another study observed cerebral enlargement in both
boys and girls with ASD compared to controls, and boys
with regressive autism showed more structural alterations
as compared to girls25. Volumetric MR studies demon-
strated a 5–10% increase in brain volume of ASD children
who were scanned between 18 months and 4 years23,26.
Imaging studies have observed both decreased and
increased cortical thickness in patients with ASD. One
study, performed on eight autistic subjects, showed
decreased cortical thickness in the regions of inferior
frontal, occipital, supramarginal, and post- and precentral
gyrus, anterior cingulate, prefrontal, parietal, and tem-
poral cortex27. Another study showed increased cortical
thickness in the parietal and temporal lobes of autistic
children compared to healthy controls28. An MRI study of
adults with ASD, who had delayed language development,
also called high‐functioning autism (HFA), observed
increased cortical thickness in frontal, occipital, temporal,
parietal, cingulate, and fusiform gyri while decreased
cortical thickness was observed in the post- and para-
central gyrus29. Surface-based morphometry (SBM) ana-
lysis is also used to measure cortical thickness in ASD
patients. An SBM based study found decreased cortical
thickness in the left orbitofrontal and parahippocampal
gyrus, left frontal pole, and pars triangularis, while
increased cortical thickness was observed in the left pre-
cuneus and anterior cingulate cortex30. Another SBM
based study reported reduced cortical volume in the left
middle temporal gyrus, reduced gyrification index in the
left supramarginal gyrus and increased cortical thickness
in pars opercularis of inferior frontal gyrus in HFA
compared to TD individuals31. The SBM approach was
also used to compare the cortical abnormalities in indi-
viduals with low‐functioning autism (LFA) and HFA and
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Asperger’s syndrome with TD controls. In HFA indivi-
duals, shape abnormality was observed bilaterally in par-
ietal operculum and ventral postcentral gyrus. LFA
individuals showed shape abnormality in the pars oper-
cularis located in the inferior frontal gyrus, and indivi-
duals with Asperger’s syndrome showed bilateral
abnormalities in the intraparietal sulcus region32. Voxel-
based morphometry analysis observed increased GM
volume in frontal, parietal, temporal lobes and limbic
system and reduced WM volume in limbic system, frontal
and temporal lobes of autistic subjects33. Another voxel-
based morphometry study showed reduced GM volumes
in frontal, temporal, and parietal lobes in HFA individuals
compared to healthy controls34.
Diffusion tensor imaging (DTI), a noninvasive MRI
technique, exploits the diffusion properties of a water
molecule to map the microstructural, architectural, and
compositional characteristics of the tissue. Fractional
anisotropy (FA) and mean diffusivity are two commonly
used DTI metrices in mapping the restricted movement of
water molecules in the tissue, where higher FA associates
with the greater directionality and tissue integrity35. DTI is
widely used to track the changes in the microstructural
properties of WM such as axonal density, axonal injury,
and myelination in various human brain’ disorders. Pro-
vided that ASD is a developmental disorder, DTI can be
used to identify variations in WM to better define devel-
opmental trajectories in individuals with ASD36. Increased
FA was observed in the frontal lobes and corpus callosum
regions of children aged 2–3 years with ASD compared to
healthy controls37. While, another study showed reduced
FA in frontal–posterior tracts in the brain of children with
ASD, aged 10–18 years38. DTI studies showed a difference
in trajectories of FA in infants aged 6–24 months who
were at higher family risk of developing ASD. FA was
higher in infants who had ASD diagnosis at the age of
6 months, while FA was found to be lower at the age of
24 months39. One study reported decreased FA in the
parietal lobes, temporal lobes, lateral occipital cortex, left
anterior cingulate, middle frontal cortex, and in the cor-
ticospinal tract of individuals with HFA as compared to
the controls34. DTI tractography confirmed abnormality of
the WM structures in the regions of the corpus callosum,
inferior longitudinal and fronto-occipital fasciculus, and
superior longitudinal fasciculus in ASD patients40.
Genes affecting brain morphology
Preclinical studies
While there may be several specific genes affected in
autism, there is increasing evidence that these genes
converge on a limited number of biological pathways that
include changes in cortical development, synapse func-
tion, transcription and translation, chromatin modifica-
tion, and microglial activation41,42 (Table 1).
Neuroligin-3 (NL3) is a major cell adhesion protein that
plays a vital role in the development of the synapse, and it
has also been implicated in ASD. An ex vivo MRI study
showed a reduction in various WM and GM regions of
NL3 knockin mice, with deficits in social and anxiety-
related behaviors43. A similar study used MRI to image
mouse models with mutations implicated in autism, such
as NL3 knockin, MECP2, and integrin β3 (ITGB3)
homozygous knockout mouse models to investigate the
effects of these mutations on brain morphology44. The
study found enlarged WM, and GM volumes of crus II
lobule in NL3 mutants increased cerebellar volumes in
MECP2 mutants and reduced cerebellar structures in
ITGB3mutants44. A neuroimaging study reported reduced
total brain volume and hippocampal size with enlarged
basal ganglia structures in SHANK3 knockout mice com-
pared to a prenatal zinc-deficient mouse model of ASD45.
A recent study on mice with ANK2 mutations showed
an increased number of excitatory synapses during post-
natal development with increased axonal branching,
which supports the presence of altered connectivity and
penetrant behavioral impairments in mice and humans
carrying ASD-related ANK2 mutations46. Mutations in
CHD2 have been linked with various neurodevelopmental
disorders, including ASD47. CHD2 is shown to play an
essential role in brain development as the suppression of
CHD2 can inhibit the self-renewing ability of radial glial
cells and can increase the generation of intermediate
progenitor cells and neurons during the process of neu-
rogenesis that might contribute to abnormal neurodeve-
lopment48. Another study showed that CHD2 knockdown
zebrafish exhibited altered locomotor activity, which
contributed to epileptic encephalopathy49. These studies
show that there is a genetic overlap found between ASD
disorder and other neurological disorders such as schi-
zophrenia, epilepsy, and ID50. In addition, knockdown of
CHD8 resulted in reduced axon and dendritic growth
with delayed neuronal migration in mice51. CHD8 sup-
pression in zebrafish affected the gene expression in
neurodevelopmental pathways related to the proliferation
of neural progenitor cells52.
One of the studies showed that mice mutants of
HOXA1/HOXB1 had several defects, including the loss of
rhombomere 4 and 5 and the loss of 2nd branchial arch
affecting the development of the hindbrain53. Previous
studies have shown the role of 16p11 deletions54 and the
CHD8 gene55 in the brain overgrowth in idiopathic ASD.
The postnatal development mechanisms such as pruning
and dendritic arborization are affected by the over-
proliferation of cortical progenitor cells. The over-
production of neocortical neurons also contributed to the
autistic-like features in mice56. Studies have reported that
16p11 deletions resulted in the alteration of cortical
progenitor cell proliferation in mice and increased brain
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volumes in individuals with syndromic ASD54. One of the
genes associated with the 16p11.2 region known as
TAOK2 has been found to cause ASD-related cognitive
abnormalities57. A neuroimaging study found dosage-
dependent abnormalities in TAOK2 heterozygous and
knockout mice. MRI of the TAOK2 knockout mice
revealed enlarged midbrain, hindbrain, hypothalamus,
thalamus, cerebellum, and hippocampus volumes, with a
regional delay in the development of the neuronal track in
the medial corpus callosum57.
Animal studies have shown that the MET protein reg-
ulates early cortical development in the neurobiology of
ASD. A study by Qiu et al. showed excitatory hypercon-
nectivity in neocortical circuits of Met conditional
knockout mice58. While another study showed that the
reduction of MET and HGF/SF correlated with calbindin
+ interneurons in the cortex of urokinase-type plasmi-
nogen activator receptor knockout mouse, thereby
affecting cortical development59.
Clinical studies
In the clinical setting, several imaging studies were
conducted that link specific gene polymorphisms with
abnormal brain morphology in ASD patients (Table 1).
Gene deletions such as 22q11.2 and 16p11.2 are asso-
ciated with ASD. These deletions are also found to be
linked with other neuropsychiatric disorders, including
DiGeorge Syndrome, conotruncal anomaly face syn-
drome, velocardiofacial syndrome, intellectual disability,
and schizophrenia60,61. 22q11.2 deletion in patients having
high-risk negative symptoms at risk of developing schi-
zophrenia showed decreased gyrification mainly in the
medial occipital and temporal regions, involved in social
cognition and early visual processing62. Another study
reported increased cortical thickness in the frontal lobe,
cerebral cortex, and superior parietal lobes and decreased
cortical thickness in the regions of superior temporal
gyrus and posterior cingulate cortex in patients with
22q11.2 deletion syndrome63.
Head circumference is abnormally increased in ASD
patients64. Many factors can be responsible for the brain
overgrowth in ASD, such as altered synapses during the
development process, increased neurites or the number of
neurons in the brain. HOX genes play an essential role in
the development of organs and are responsible for the
proper positioning of organism’s segment structures
during embryonic development (Fig. 1). Out of all the
HOX genes, HOXA1 is a critical gene that is involved in
the development of the central nervous system, internal
ear, and hyoid bones65,66. HOXA1 polymorphism has been
found to induce an increased head growth rate in autistic
and TD children67. In addition, autistic individuals with
HOXA1 A218G polymorphism displayed an enlarged
cranial circumference68, while in autistic patients, one
study reported minor contributions of the HOXB1 gene to
head circumference69.
Mutations in PTEN have also been associated with brain
morphological changes in ASD. PTEN mutations have
been observed in Cowden syndrome, and macrocephaly is
the main feature of patients with Cowden syndrome, and
some of the individuals with this syndrome are also found
to be autistic70,71. Sequencing of the PTEN gene in ASD
patients revealed three heterozygous germline muta-
tions72 and a missense mutation73. An ASD-related syn-
drome, known as cortical dysplasia-focal epilepsy (CDFE)
is a rare neuronal migration disorder, and patients with
CDFE exhibit autistic characteristics. A study reported a
homozygous mutation in the CNTNAP2 gene in all CDFE
patients, which is responsible for an early developmental
insult, mainly in the frontal and temporal neocortex74.
Another study showed that the impact of CNTNAP2
missense variants on axonal growth as the loss of
Fig. 1 Structural brain changes associated with HOX genes. HOXA1 A218 gene polymorphism is associated with an increased head
circumference in autistic individuals, and HOXA1/HOXB1 mice mutants showed loss of rhombomeres 4 and 5 affecting the hindbrain
development53,68.
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CNTNAP2 allele contributes to the disruption in axonal
growth75. An MRI study investigated the homozygous
c.3709DelG mutation in CNTNAP2 in the forebrain
organoids generated from human induced pluripotent
stem cells that were derived from patients with syndromic
ASD. The study found that individuals with c.3709DelG
mutation in CNTNAP2 displayed increased head cir-
cumference and increased GM volume76. An imaging
genetic study found an association of CNTNAP2 rs779475
single-nucleotide polymorphism with WM and GM
morphology in healthy controls and observed reduced
volume of GM in the regions of frontal and occipital lobes
and cerebellum. However, there was a reduction in the
WM volume in the regions of right rostral cingulum, right
caudal inferior fronto-occipital fasciculus, and the pos-
terior thalamic radiations in homozygotes for the risk
allele (rs779475 T/T) as compared to the nonrisk homo-
zygotes and a group of rs779475T heterozygotes77.
Mutations in the chromodomain helicase DNA binding
protein 8 (CHD8) gene, which plays a vital role in the
chromatin remodeling process, are amongst the most
commonly reported mutations in ASD. CHD8 mutations
have also been linked with axonal and dendritic growth,
and a study showed that CHD8 is highly expressed in a
microtubule-associated-protein 2 positive neurons and
parvalbumin neurons which plays an essential role in the
development of neocortex in the human brain. The
findings of the study suggested that CHD8 mutations in
humans can result in neuronal deficits that can contribute
to ASD pathophysiology51.
Studies have proposed the association of MET proto-
oncogene, receptor tyrosine kinase (MET), as a candidate
risk gene for ASD. In order to find the association of MET
with cortical development, a structural MRI study inves-
tigated the relationship between a single-nucleotide
polymorphism within the MET promoter (rs1858830,
G→C) and the development of cortical thickness in ASD
individuals. The study observed cortical thickness reduc-
tion in the regions of ventral precentral and postcentral
gyri, superior and middle temporal gyri, anterior cingulate
cortex, and in the right fronto-polar cortex with increas-
ing C allele dose78. Another study found that MET risk
allele carrier (rs1858830) individuals with ASD and TD
showed higher activation of amygdala, reduced WM
integrity, and reduced connectivity between the posterior
cingulate cortex and medial prefrontal cortex (mPFC)79.
A common polymorphism in the serotonin-transporter
gene (SLC6A4) involving a serotonin-transporter related
polymorphic region (5HTTLPR) results in the generation
of short or long alleles. A study by Wassink et al. found
that the 5HTTLPR short allele significantly influences the
cortical GM volumes in male autistic children80. Several
neuroimaging studies have investigated the effects of
different oxytocin receptor (OXTR) risk alleles
(rs2254298, rs53576, rs226849, rs401015) on brain mor-
phological changes in healthy adults81–89. OXTR risk allele
carriers (rs2254298) showed increased amygdala
volume81,82,89, decreased GM volume in the hypothala-
mus83, and right insula84. A study showed that dysregu-
lation in the β-catenin/BRN2 transcriptional cascade was
associated with an increased number of neurons and
proliferation of neural progenitor cells derived from
pluripotent stem cells of ASD individuals and also con-
tributed to increased brain volumes90.
Functional brain changes
Resting-state fMRI (rsfMRI) is a powerful tool that is
being used for mapping the neuronal activity of various
neurological disorders. rsfMRI studies have revealed
abnormalities in the neuronal network in ASD patients
that help in understanding the underlying neurobiology of
ASD. An rsfMRI study observed altered functional con-
nectivity between the cerebral cortex and dentate nucleus
in individuals with ASD, which is suggestive of impaired
interaction between the cerebellum and social cortical
regions of the brain91. Another study observed reduced
integration of the default mode network with the mPFC
and angular gyrus regions in the ASD group92. The mPFC
region is mainly involved in decision making, and one of
its primary function is encoding task-related information
in the working memory93, while angular gyrus is involved
in semantic processing, default mode network, social
cognition, and memory retrieval and attention94. Another
rsfMRI study showed that the underconnectivity in the
temporal sulcus, which is a human voice processing
region, in ASD children in addition to a decreased con-
nectivity in reward-related regions in the brain of ASD
children. While task-based fMRI showed altered network
connectivity in multiple brain regions that control social
and emotional processing in ASD95. A sentence com-
prehension task-based study showed decreased con-
nectivity in cortical areas of ASD individuals, which
signifies the low congruence of brain regions that are
essential for integrating information96. Other task-based
studies have also reported decreased connectivity in the
fronto-parietal regions that are involved in working
memory (n-back working memory task)97, facial proces-
sing (emotional facial processing task)98, response inhi-
bition (simple inhibition/1-back inhibition task)99 and
visuomotor coordination (measuring BOLD signal)100 in
ASD individuals. Task-based study based on social pro-
cessing found hypoactivation in social brain nodes in the
regions of the mPFC, frontal gyrus, insula, temporal sul-
cus, amygdala, and the fusiform gyrus101.
Task-based fMRI studies focused on cognitive control
reported fronto-striatal dysfunction in ASD, specifically in
frontal gyrus, basal ganglia, and anterior cingulate cortex
regions. Task-based studies that involved examining brain
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responses associated with figures of speech like puns102
and examining the neural activity during the detection of
senseless sentences103 have also shown communication
impairments such as decreased brain synchrony in lan-
guage processing regions in ASD102,103. Task-based stu-
dies focusing on reward processing showed impairments
in mesolimbic and meso cortical brain regions in ASD.
Both over connectivity and underconnectivity between
frontal and posterior regions was observed in task-based
functional connectivity study104. An fMRI study revealed
that ASD individuals had reduced activation of higher-
order social (fusiform, cingulate, amygdala, gyrus, insula)
and executive processing (prefrontal cortex) of the brain
and higher activation of lower-order structures that are
involved in the mediation of primary motor and sensory
processing during emotional task performance105. While
some task-based studies such as source recognition
task106 and emotional face processing task107 have
reported increased connectivity between the brain regions
of ASD individuals106,107.
Limitations of functional imaging in ASD
Neuroimaging can help bridge the gap between genes,
environment, and different ASD behavioral phenotypes.
Although functional imaging techniques such as fMRI
have revolutionized the understanding of various mental
disorders, the fMRI technique also contains several lim-
itations. The big challenge in current fMRI-based meth-
ods is the impact of age/gender and the development of
scanning techniques for the diagnosis of ASD across
heterogeneous populations. One of the limitations of
fMRI is that it has no role in measuring the direct neu-
ronal activity instead it provides changes in the signal
based on the blood oxygen level, which may lead to the
false-positive or -negative signal specially in patients with
abrupt behavioral changes such as ASD. Secondly, an
individual’s performance on a specific task must be con-
sidered in a task-based fMRI and must be well-thought-
out when analyzing the fMRI data. The fMRI data are also
analyzed as group averages; therefore, it is not straight-
forward to diagnose individual autistic patients. This
could be par by introducing an individualized diagnostic
model based on artificial intelligence.
Furthermore, the data obtained from fMRI may be
compromised to some extent due to head motion artifacts
that alter voxel and stable state magnetization leading to
distortion of anatomical locations and may show false
regions associated with brain activity. In addition, fMRI
data can only demonstrate that a particular region of the
brain is involved in a specific cognitive function but
cannot determine whether it is a cause or a consequence
of that specific cognitive function. The lack of longitudinal
data also makes it challenging to identify the abnormal
developmental course in ASD during infancy.
Nevertheless, the integration of multiple sites and data
sources and the increase in the number of subjects and
intra-variability among subjects can improve the feasi-
bility of the fMRI technique in ASD.
Genes affecting brain functions
Preclinical studies
Reduced levels of oxytocin have been found in ASD
patients, and CD38 is a vital enzyme that controls oxy-
tocin production. A CD38−/− mice study showed abnor-
mal development of the cortex and impaired synaptic
plasticity in the prefrontal cortex region with impaired
social and emotional responses108 (Table 1). Genetic
variations in the 1A gene of the arginine vasopressin
receptor (AVPR1A) were linked to autism. Impaired social
recognition and reduced anxiety behaviors were observed
in knockout mice of AVPR1A, while overexpression of
AVPR1A in mice led to increased social memory109,110.
There is also an inversion of cortical layering due to
neuronal migration defects in the Reelin (RELN) knockout
mice111, resulting in various behavioral abnormalities,
such as aggressive behavior and memory and learning
impairments112. CNVs of the cytoplasmic FMR1-
interacting protein 1 (CYFIP1) was found to be asso-
ciated with ASD and other neuropsychiatric disorders
such as schizophrenia. CYFIP1 plays an essential part in
regional brain connectivity and corpus callosum function.
A study found that the CYFIP1-heterozygous mice dis-
played reduced bilateral functional connectivity across the
entire brain and defects in the WM architecture. In these
mice, reduced myelination is also observed in the callosal
axons, an altered presynaptic feature that contributes to
the motor and sensorimotor abnormalities113.
Another rsfMRI study showed decreased local and long-
range functional connectivity in prefrontal and midbrain
of mice with the homozygous loss of CNTNAP2 and may
contribute to the development of autistic-like features and
other neurodevelopment disorders114.
Clinical studies
Imaging genetics studies have shown the involvement of
ASD risk genes in altering the brain circuits that control
reward and language processing, and social behavior (Table
1). Neurexin-1 (NRXN1) is one of the ASD risk genes that
are found to influence the brain structure and functions,
and its polymorphisms are found to be associated with
structural alterations in the prefrontal–thalamic circuitry in
healthy individuals, conferring a potential risk of developing
ASD or schizophrenia115. Single-cell analysis of neural stem
cells from an autistic patient with bi-allelic NRXN1-α
deletion observed a phenotypic shift toward radial glia-like
cell with impaired maturation action potential and reduced
calcium signaling116. On the other hand, CNTNAP2 poly-
morphisms are found to be associated with altered brain
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connectivity in regions that are involved in reward and
language development117 (Fig. 2). Healthy individuals car-
rying the risk alleles for ASD and language impairment
(rs7794745 T, rs2710102 C) showed increased activation in
the right inferior frontal gyrus and right lateral temporal
cortex118. Mutations in the genes involved in the oxytocin/
vasopressin system may also contribute to ASD risk as they
influence the function of brain regions such as the amygdala
and hypothalamus that are associated with emotional and
social processing119,120 (Fig. 3). Studies have found an
association between a common genetic variant in CD38
(rs3796863), autism, and the impact of oxytocin levels on
brain response to social stimuli119,121. An fMRI study
observed increased activation of the left fusiform gyrus in
homozygotes for CD38 genetic variant rs3796863119. The
MET gene variants are also found to be involved in altering
the connectivity and integrity of WM in the temporo-
parieto-occipital regions that are involved in high neurolo-
gical functions such as working memory, language proces-
sing, and face and object recognition, all that may
predispose an individual to ASD79. Another study reported
that the loss of CNTNAP2 contributed to the reduction in
long-range connectivity in the brain regions of mice, mainly
affecting the prefrontal regions that act as connectivity hubs
in the brain122 and this hypoconnectivity in the fronto-
posterior region lead to impaired social behaviors, predis-
posing to autism risk114. The OXTR polymorphism
rs1042778 is found to be associated with two common
clinical phenotypes of ASD, such as aggression and panic in
male ASD patients. As compared to GG homozygotes, the
T-allele carriers were at higher risk of possessing aggressive
and panic behaviors123. Some of the task-based fMRI stu-
dies in healthy individuals carrying the OXTR risk alleles
showed increased activation of inferior occipital gyrus
during a fear processing task86, decreased activation in the
mesolimbic reward circuitry in a reward anticipation task85
and increased amygdala activity during a direct gaze pro-
cessing task87. One study found elevated levels of AVP with
reduced levels of apelin in ASD patients that point to the
vasopressinergic dysfunction in autism124. Another study
proposed that the shorter alleles of RS1 polymorphism lead
to reduced transcription of AVPR1A that may increase the
susceptibility to ASD125. An fMRI study found an associa-
tion between ASD and AVPR1A genetic variants and
reported differential activation of amygdala during a face-
matching task in RS1 and RS3 risk allele carriers120.
Reduced expression of three genes namely metaxin 2
(MTX2), neurofilament light polypeptide (NEFL), and
solute carrier family 25, member 27 (SLC25A27) was
found in the anterior cingulate gyrus, the motor cortex,
and thalamus regions of autistic patients. NEFL plays a
vital role in the maintenance and assembly of the axonal
cytoskeleton126, while SLC25A27 is expressed in the
central nervous system and has been found to play an
essential role in neuronal cell differentiation127, apoptosis
inhibition128, and reduction of reactive oxygen species129.
One of the critical regulators of neuronal migration is
RELN glycoprotein, shown to play a vital role in the
Fig. 2 Specific studies in humans and mice with ASD showing functional brain changes correlated with CNTNAP2 gene. The CNTNAP2 gene
is associated with increased frontal lobe connectivity117 and increased connectivity in ASD risk allele carriers within Broca’s area118. Studies on mice
show that the loss of CNTNAP2 gene impairs axonal growth75, reduces functional connectivity in the prefrontal cortex114, and hyperactive AKT/mTOR
pathway149.
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neuron layering. Aberrant reelin signaling has been
reported in many studies in individuals with ASD130–132.
RELN mutations disrupt neuronal migration and con-
nectivity and cerebellar hypoplasia133. A significant
reduction in the RELN protein has also been observed in
the cerebellum of autistic individuals132. Another gene T-
Box Brain Protein 1 that encodes a brain-specific T-box
transcription factor plays an essential role in the neuronal
development, axonal migration, and the development of
the cerebral cortex and amygdala134. This gene has been
identified as an ASD causative gene135 and is involved in
the differentiation of neurons during the early develop-
ment of neocortex136.
Diagnostic models of ASD
Diagnostic models based on MR-derived features
MRI-based diagnostic models are used for the behavioral
assessment of autistic patients. These diagnostic model
studies involve three steps, including extraction of proper-
ties from MR images, construction of diagnostic model
using statistical models followed by evaluation and valida-
tion by researchers. Several studies have focussed on MRI-
based diagnostic models for the detection and classification
of ASD30,137. Diagnostic model performance is strongly
influenced by types of entities selected as components of the
model. For example, a study showed the comparison of
diagnostic models based on regional thickness derived from
surface morphometry (SBM) with diagnostic models based
on volumetric morphometry involving four different clas-
sification methods and classification based on thickness was
found to be more efficient and predictive of ASD compared
to classification based on volume30. rsfMRI pipelines have
been used to extract predictive biomarkers in autism by
constructing participant-specific connectomes and then
comparing these connectomes across participants to learn
connectivity patterns that may identify ASD individuals138.
The results suggested that rsfMRI data collected from dif-
ferent sites could reveal robust functional connectivity
biomarkers of ASD.
Diagnostic models based on imaging genetics
Imaging genetics in ASD has proven useful, and path-
ways that include common genetic variation in TD indi-
viduals at risk of developing ASD have been characterized.
Prenatal transcription regulation and synapse formation
in the developing brain is impacted by the genes asso-
ciated with ASD (Table 1). Alteration in frontal WM
connectivity and structure and disturbance in the frontal,
temporal, and occipital circuits involved in visual and
language processing was found to be associated with
NRXN superfamily genes115. Neuropeptide signaling and
emotional functioning was found to be influenced by the
oxytocin and arginine vasopressin receptor genes via
structural and functional modification in the
Fig. 3 Oxytocin and vasopressin (OT-AVP) pathway associated with social behavior in ASD. In the hypothalamus, magnocellular neurons
originating from paraventricular and supraoptic nuclei release oxytocin and vasopressin in the posterior pituitary which then goes into the peripheral
circulation. Any deficiencies in oxytocin or vasopressin levels contribute to ASD’s social behavioral impairments.
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amygdala–hypothalamus circuitry77. One study showed a
relationship between frontal lobe connectivity and com-
mon genetic variants in CNTNAP2 using a functional
neuroimaging study117 and the study found that ASD and
TD individuals who were nonrisk allele carriers showed
more reduction in the activation of mPFC during an fMRI
task as compared to risk allele carriers117. Another study
showed decreased functional connectivity in the pre-
frontal cortex, cortical spinal tract, corpus callosum, and
decreased integrity of WM in children and adolescents
carrying MET rs1858830, C risk allele. Such studies sug-
gest that the genes affect the brain regions that are
involved in social and emotional processing139.
More detailed brain analysis combined with visualiza-
tion, will promote the elucidation of the relationship
between genes and altered neuronal circuits. Also,
researching the time-dependent impacts of ASD-involved
genetic variants that are the cause of neurodevelopmental
modification can aid in the progress of ASD imaging
genetics. In addition, the plasticity that is altered in dif-
ferent neuropsychiatric disorders such as ASD can be
measured with high resolution by combining electro-
encephalography or fMRI with transcranial magnetic sti-
mulation. Advances in noninvasive brain imaging
techniques and scans during rest or task may help in
infant neuroimaging that are at a higher risk to develop
ASD. With studies investigating genetic effects on brain
development using high-resolution imaging, studying
brain-behavior connections and the impact of new
therapies on brain development, further translational
progress will happen in the future. By neuroimaging
endophenotypes, a greater understanding of the impact of
ASD risk genes on the brain circuitry139 can be achieved.
Ultimately, imaging genetics in ASD might be promising
for the clinical management of ASD-affected patients.
Challenges and future perspectives
The field of imaging genetics has exponentially grown in
recent decades from its candidate gene studies to large-
scale longitudinal studies, cross-modal investigations, and
translational animal models of various psychiatric dis-
orders. In addition, imaging genetics has begun integrat-
ing transcriptomic data and analytical methods for
assessing pathway enrichment, such as the score system
for pathway regulation. Of addition to translational ani-
mal research and pharmacological intervention in vitro
and in vivo, imaging genetics can also provide an insight
into various behavioral and genetic factors that contribute
to the risk of ASDs.
One of the challenges facing imaging genetics is the
conceptualization of endophenotypes, which states that
endophenotypes are heritable and associated with psy-
chiatric disorders and may impede research on brain-
based associations by limiting imaging genetic research to
genes previously associated with a psychiatric disorder140.
It is important to properly replicate the studies, particu-
larly those with false-positive results, to address the
impact of a genetic variation in a disease, and this pro-
blem can be solved by correcting genome-wide associa-
tions with large sample size imaging phenotypes.
Another challenge in ASD neuroimaging research is the
discrepancy in the brain connectivity findings due to
motion artifacts. The motion artifacts in the rsfMRI data
can misrepresent group differences in connectivity
metrics which can lead to incorrect interpretation of the
altered brain connectivity data in ASD. Other methodo-
logical variables such as pipeline type, field of view, and
dataset can significantly impact (in terms of over-or
underconnectivity) the functional connectivity MRI stu-
dies in ASD141. Also, the differences in age and severity of
the ASD cohort may lead to disparity in findings, and so
large-scale studies are required that concentrate on
exploring the developmental trajectories that are crucial
to understanding the neurobiology underlying ASD. Such
large-scale study databases can be obtained from various
consortia, such as autism brain imaging data exchange
and National Autism Research Database (NDAR). The
heterogeneity of the ASD phenotypes, therefore, leads to
the difficulties faced in ASD neuroimaging genetics as
there is a high degree of variability in frequency, the
number of behavioral symptoms reported, and the asso-
ciated characteristics in ASD. In addition, the brain
responses produced as a result of a particular task sti-
mulus are inadequate to determine if these responses
result from a neural processing disorder or are due to the
introduction of an extrinsic factor.
In addition, more development in data analytical
methods such as machine learning algorithms or software
can allow data from multiple modalities to be incorpo-
rated into a heterogeneous population, and can also
recognize and detect digital biomarkers142 that can be
used for the clinical management of ASD patients.
Conclusion
To explain the origin of ASD’s underlying pathophysiology,
the study of genetic alterations and the relationship between
genes and environmental factors is crucial. Imaging genetics
studies have revealed important information about the
pathophysiology of ASD. One of the key aims of imaging
genetics studies in ASD is to elucidate neural pathways that
give rise to phenotypical heterogeneity. Enhanced risk of
ASD is shown to be related to several different single-
nucleotide polymorphisms, and the stratification of neuroi-
maging data by specific genetic risk factors occurring in ASD
may help to understand the neurobiology underlying this
disorder. Such studies will help to elucidate ASD from var-
ious perspectives and subsequently will pave the way for
personalized treatment for patients with ASD.
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